Beneficial Impact of Zingiber zerumbet on Insulin Sensitivity in Fructose-Fed Rats

Abstract

Zingiber zerumbet (L) Smith (Zingiberaceae), commonly known as the pinecone or shampoo ginger, is distributed in many parts of Asia. It has been demonstrated that the aqueous extract of Z. zerumbet exerted a potential blood glucose lowering effect in normoglycemic and streptozotocin-induced hyperglycemic rats. The present study was undertaken to clarify whether the ethanol extract of Zingiber zerumbet (EEZZ) is effective in improving insulin resistance. Insulin resistance was induced in rats by feeding a high-fructose diet for six weeks. Thereafter, rats were maintained on the same diet and treated with oral EEZZ or pioglitazone once daily for eight weeks. At the end of treatment, the degree of basal insulin resistance was measured by homeostasis model assessment (HOMA-IR). Insulin sensitivity was calculated using the composite whole body insulin sensitivity index (ISIcomp). Protein expression was evaluated by immunoblotting. Phytochemicals in EEZZ were determined through liquid chromatography-tandem mass. Not only curcumin but also quercetin and kaempferol were abundant in EEZZ. EEZZ (300 mg/kg/day) displayed similar characteristics to pioglitazone (20 mg/kg/day) in reducing HOMA-IR and elevating ISIcomp as well as enhancing hepatic glycogen accumulation. Elevated glycosylated hemoglobin levels and hyperinsulinemia were ameliorated by EEZZ. Further, EEZZ enhanced the action of insulin on muscle glucose transporter subtype 4 translocation and attenuated hepatic phosphoenolpyruvate carboxykinase expression. This study suggests that EEZZ may be an ethnomedicine for improving insulin sensitivity.

fructose - glucose transporter subtype 4 - insulin resistance - phosphoenolpyruvate carboxykinase - Zingiber zerumbet - Zingiberaceae

References

• 1 Gallagher E J, Leroith D, Karnieli E. The metabolic syndrome – from insulin resistance to obesity and diabetes.  Med Clin North Am. 2011;  95 855-873
• 2 Wang Y X. PPARs: diverse regulators in energy metabolism and metabolic diseases.  Cell Res. 2010;  20 124-137
• 3 Granberry M C, Hawkins J B, Franks A M. Thiazolidinediones in patients with type 2 diabetes mellitus and heart failure.  Am J Health Syst Pharm. 2007;  64 931-936
• 4 Afzal M, Al-Hadidi D, Menon M, Pesek J, Dhami M S. Ginger: an ethnomedical, chemical and pharmacological review.  Drug Metab Drug Interact. 2001;  18 159-190
• 5 Sulaiman M R, Tengku Mohamad T A, Shaik Mossadeq W M, Moin S, Yusof M, Mokhtar A F, Zakaria Z A, Israf D A, Lajis N. Antinociceptive activity of the essential oil of Zingiber zerumbet.  Planta Med. 2010;  76 107-112
• 6 Somchit M N, Nur Shukriyah M H, Bustamam A A, Zuraini A. Anti-pyretic and analgesic activity of Zingiber zerumbet.  Int J Pharmacol. 2005;  1 277-280
• 7 Butt M S, Sultan M T. Ginger and its health claims: molecular aspects.  Crit Rev Food Sci Nutr. 2011;  51 383-393
• 8 Tan S K, Pippen R, Yusof R, Abdul Rahman N S, Ibrahim H, Khalid N Z. Screening of selected Zingiberaceae extracts for dengue-2 virus protease inhibitory activities.  Sunway Acad J. 2006;  3 1-7
• 9 Husen R, Pihie A H, Nallappan M. Screening for antihyperglycaemic activity in several local herbs of Malaysia.  J Ethnopharmacol. 2004;  95 205-208
• 10 Dekker M J, Su Q, Baker C, Rutledge A C, Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome.  Am J Physiol Endocrinol Metab. 2010;  299 E685-E694
• 11 Hyakukoku M, Higashiura K, Ura N, Murakami H, Yamaguchi K, Wang L, Furuhashi M, Togashi N, Shimamoto K. Tissue-specific impairment of insulin signaling in vasculature and skeletal muscle of fructose-fed rats.  Hypertens Res. 2003;  26 169-176
• 12 Borai A, Livingstone C, Ferns G A. The biochemical assessment of insulin resistance.  Ann Clin Biochem. 2007;  44 324-342
• 13 Ding S Y, Shen Z F, Chen Y T, Sun S J, Liu Q, Xie M Z. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.  Acta Pharmacol Sin. 2005;  26 575-580
• 14 Bloomgarden Z T. Measures of insulin sensitivity.  Clin Lab Med. 2006;  26 611-633
• 15 Van der Vies J. Two methods for the determination of glycogen in liver.  Biochem J. 1954;  57 410-416
• 16 Li X, Hansen P A, Xi L, Chandraratna R A, Burant C F. Distinct mechanisms of glucose lowering by specific agonists for peroxisomal proliferator activated receptor gamma and retinoic acid X receptors.  J Biol Chem. 2005;  280 38317-38327
• 17 Rodriguez E, Pulido N, Romero R, Arrieta F, Panadero A, Rovira A. Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle.  Endocrinology. 2004;  145 679-685
• 18 Little R R, Rohlfing C L, Sacks D B. Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care.  Clin Chem. 2011;  57 205-214
• 19 Foley K, Boguslavsky S, Klip A. Endocytosis, recycling, and regulated exocytosis of glucose transporter 4.  Biochemistry. 2011;  50 3048-3061
• 20 Boden G. Gluconeogenesis and glycogenolysis in health and diabetes.  J Invest Med. 2004;  52 375-378
• 21 Yabaluri N, Bashyam M D. Hormonal regulation of gluconeogenic gene transcription in the liver.  J Biosci. 2010;  35 473-484
• 22 Eid H M, Martineau L C, Saleem A, Muhammad A, Vallerand D, Benhaddou-Andaloussi A, Nistor L, Afshar A, Arnason J T, Haddad P S. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea.  Mol Nutr Food Res. 2010;  54 991-1003
• 23 El-Moselhy M A, Taye A, Sharkawi S S, El-Sisi S F, Ahmed A F. The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF-α and free fatty acids.  Food Chem Toxicol. 2011;  49 1129-1140
• 24 Zhang Y, Liu D. Flavonol kaempferol improves chronic hyperglycemia-impaired pancreatic beta-cell viability and insulin secretory function.  Eur J Pharmacol. 2011;  670 325-332
• 25 Lewis J D, Ferrara A, Peng T, Hedderson M, Bilker W B, Quesenberry jr. C P, Vaughn D J, Nessel L, Selby J, Strom B L. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.  Diabet Care. 2011;  34 916-922